GSDMA and cancer: Therefore, guaranteeing sufficient Gasdermin intracellular delivery, activating the related caspase signaling pathway, and preventing ESCRT-mediated cell membrane repair are progressive prerequisites for the realization and enhancement of pyroptosis-mediated cancer immunotherapy.